These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33894539)

  • 1. A binational study assessing risk and resilience factors in 22q11.2 deletion syndrome.
    Gur RE; White LK; Shani S; Barzilay R; Moore TM; Emanuel BS; Zackai EH; McDonald-McGinn DM; Matalon N; Weinberger R; Gur RC; Gothelf D
    J Psychiatr Res; 2021 Jun; 138():319-325. PubMed ID: 33894539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between intelligence quotient measures and computerized neurocognitive performance in 22q11.2 deletion syndrome.
    Gur RC; Moore TM; Weinberger R; Mekori-Domachevsky E; Gross R; Emanuel BS; Zackai EH; Moss E; Gallagher RS; McGinn DE; Crowley TB; McDonald-McGinn D; Gothelf D; Gur RE
    Brain Behav; 2021 Aug; 11(8):e2221. PubMed ID: 34213087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome.
    Yirmiya ET; Mekori-Domachevsky E; Weinberger R; Taler M; Carmel M; Gothelf D
    Am J Med Genet A; 2020 Mar; 182(3):461-468. PubMed ID: 31837200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying patterns of anxiety and depression in children with chromosome 22q11.2 deletion syndrome: comorbidity predicts behavioral difficulties and impaired functional communications.
    Stephenson DD; Beaton EA; Weems CF; Angkustsiri K; Simon TJ
    Behav Brain Res; 2015 Jan; 276():190-8. PubMed ID: 24906195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
    Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
    Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-pharmacological treatment of psychiatric disorders in individuals with 22q11.2 deletion syndrome; a systematic review.
    Buijs PCM; Bassett AS; Boot E
    Am J Med Genet A; 2018 Aug; 176(8):1742-1747. PubMed ID: 29363845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthreshold social cognitive deficits may be a key to distinguish 22q11.2DS from schizophrenia.
    Peyroux E; Rigard C; Saucourt G; Poisson A; Plasse J; Franck N; Demily C
    Early Interv Psychiatry; 2019 Apr; 13(2):304-307. PubMed ID: 29575660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resilience and quality of life in young adults with a 22q11.2 deletion syndrome: a patient's perspective.
    Van de Woestyne K; Vandensande A; Vansteelandt K; Maes B; Vergaelen E; Swillen A
    Eur Child Adolesc Psychiatry; 2022 Dec; 31(12):1885-1894. PubMed ID: 34115224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typical 22q11.2 deletion syndrome appears to confer a reduced risk of schwannoma.
    Evans DG; Messiaen LM; Foulkes WD; Irving REA; Murray AJ; Perez-Becerril C; Rivera B; McDonald-McGinn DM; Stevenson DA; Smith MJ
    Genet Med; 2021 Sep; 23(9):1779-1782. PubMed ID: 33879870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes.
    Zarchi O; Diamond A; Weinberger R; Abbott D; Carmel M; Frisch A; Michaelovsky E; Gruber R; Green T; Weizman A; Gothelf D
    Eur Psychiatry; 2014 May; 29(4):203-10. PubMed ID: 24054518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of fatigue in adults with a 22q11.2 deletion syndrome.
    Vergaelen E; Claes S; Kempke S; Swillen A
    Am J Med Genet A; 2017 Apr; 173(4):858-867. PubMed ID: 28190295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk.
    Francisco AA; Horsthuis DJ; Popiel M; Foxe JJ; Molholm S
    Neuroimage Clin; 2020; 27():102351. PubMed ID: 32731196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.
    Gothelf D; Schneider M; Green T; Debbané M; Frisch A; Glaser B; Zilkha H; Schaer M; Weizman A; Eliez S
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1192-1203.e3. PubMed ID: 24157393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome.
    Niarchou M; Martin J; Thapar A; Owen MJ; van den Bree MB
    Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):730-8. PubMed ID: 26400629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety.
    Scott JA; Goodrich-Hunsaker N; Kalish K; Lee A; Hunsaker MR; Schumann CM; Carmichael OT; Simon TJ
    J Psychiatry Neurosci; 2016 Apr; 41(3):203-13. PubMed ID: 26599134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
    Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
    Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
    Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
    J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
    Hooper SR; Shashi V
    Schizophr Res; 2017 Oct; 188():33-34. PubMed ID: 28768602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.